ALZAMEND NEURO INC
ALZN·02262M605·US·Common Stock·Healthcare - Biotechnology-Activist
ALZN (ALZAMEND NEURO INC) is held by 5 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($31,644), VANGUARD FIDUCIARY TRUST CO ($25,224), VANGUARD CAPITAL MANAGEMENT LLC ($9,067). Net institutional sentiment: Bearish.
5
Holders
$69,281
Total Value
20% (5)
Consensus
1 buying - 4 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 27, 2026 · Insiders Dec 30, 2025 · Activists Oct 7, 2025 · Congress none
InsiderAIAULT MILTON C IIISell $4KDec 23, 2025
InsiderHBHorne William B.Sell $7KDec 19, 2025
InsiderMFMcGrath Lynne FaheySell $68.7Oct 23, 2025
Checking access…
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer